ARTICLE | Translation in Brief
To eat and not to eat
New way to boost ‘eat me’ signal on cancer cells could complement CD47 blockade
September 19, 2018 9:32 PM UTC
A Nature Communications paper published last month by Forty Seven Inc. (NASDAQ:FTSV) co-founder Irving Weissman and colleagues at Stanford University highlights a new strategy for boosting “eat me” signals on cancer cells that could complement CD47 blockade.
Weissman is a professor of pathology and developmental biology and director of the Institute of Stem Cell Biology and Regenerative Medicine at Stanford, as well as a member of Forty Seven’s board...
BCIQ Target Profiles